Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular Effects of Very Low Nicotine Content Cigarettes
NCT05707871Phase 1Recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Apr 2023
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1 trial of cigarette reduced nicotine in Tobacco Use Disorder (TUD) (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: Change in Heart rate. Started Apr 2023; status: recruiting.
02
Drugs
cigarette reduced nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT05707871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05707871.